106 related articles for article (PubMed ID: 3947107)
1. [Comparative studies of antitumor activities of oxalate (1R, 2R-cyclohexanediammine) platinum (II) and cis-dichlorodiammine-platinum (II) using ovarian cancer transplanted into nude mice].
Suzumori K; Yasui Y; Asai H; Yagami Y
Gan To Kagaku Ryoho; 1986 Feb; 13(2):280-5. PubMed ID: 3947107
[TBL] [Abstract][Full Text] [Related]
2. [Comparative studies of the antitumor activities of CDDP and the analogs--using gynecological carcinomas transplanted into nude mice].
Suzumori K; Yasui Y; Suzumori K; Yagami Y
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 1):387-91. PubMed ID: 2649007
[TBL] [Abstract][Full Text] [Related]
3. Antitumor effects of a new lipophilic platinum compound, trans-bis(n-valerato)(1R,2R-cyclohexanediamine)(oxalato)platinum(IV), in mice.
Saegusa Y; Eriguchi M; Kidani Y; Matsuzawa A; Takeda Y
Anticancer Res; 2001; 21(1A):245-52. PubMed ID: 11299742
[TBL] [Abstract][Full Text] [Related]
4. [Effect of a newly developed platinum compound cis-1, 1-cyclobutane dicarboxylato-(2R)-2-methyl-1,4-butane diamine platinum (II), on human ovarian tumors transplanted into nude mice].
Sawada M; Ozaki M; Taniguchi H; Tateishi R; Mori Y; Mino K
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):637-41. PubMed ID: 3355185
[TBL] [Abstract][Full Text] [Related]
5. [Antitumor activity of platinum analogs against human ovarian tumors heterotransplanted into nude mice].
Sawada M; Ozaki M; Hongo J; Hirota Y; Inagaki M; Taniguchi H; Tateishi R; Mori Y
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):693-8. PubMed ID: 3548596
[TBL] [Abstract][Full Text] [Related]
6. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
[TBL] [Abstract][Full Text] [Related]
7. Preparation of antitumor oxaliplatin/cisplatin docking dinuclear platinum complex.
Noji M; Kizu R; Takeda Y; Akiyama N; Yoshizaki I; Eriguchi M; Kidani Y
Biomed Pharmacother; 2005 Jun; 59(5):224-9. PubMed ID: 15919175
[TBL] [Abstract][Full Text] [Related]
8. A new orally active antitumor 1R,2R-cyclohexanediamine-platinum(IV) complex: trans-(n-valerato)chloro(1R,2R-cyclohexanediamine) (oxalato)platinum(IV).
Kizu R; Nakanishi T; Hayakawa K; Matsuzawa A; Eriguchi M; Takeda Y; Akiyama N; Tashiro T; Kidani Y
Cancer Chemother Pharmacol; 1999; 43(2):97-105. PubMed ID: 9923814
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of a new platinum complex, oxalato (trans-l-1,2-diaminocyclohexane)platinum (II): new experimental data.
Tashiro T; Kawada Y; Sakurai Y; Kidani Y
Biomed Pharmacother; 1989; 43(4):251-60. PubMed ID: 2790145
[TBL] [Abstract][Full Text] [Related]
10. Comparative activity and distribution studies of five platinum analogues in nude mice bearing human ovarian carcinoma xenografts.
Boven E; van der Vijgh WJ; Nauta MM; Schlüper HM; Pinedo HM
Cancer Res; 1985 Jan; 45(1):86-90. PubMed ID: 4038381
[TBL] [Abstract][Full Text] [Related]
11. An orally active antitumor cyclohexanediamine-Pt(IV) complex: trans,cis,cis-bis(n-valerato)(oxalato)(1R,2R-cyclohexane diamine)Pt(IV).
Kizu R; Nakanishi T; Miyazaki M; Tashiro T; Noji M; Matsuzawa A; Eriguchi M; Takeda Y; Akiyama N; Kidani Y
Anticancer Drugs; 1996 May; 7(3):248-56. PubMed ID: 8791997
[TBL] [Abstract][Full Text] [Related]
12. Secondary screening of platinum compounds in human ovarian cancer xenografts in nude mice.
Boven E; Nauta MM; Schluper HM; Elferink F; van der Vijgh WJ; Pinedo HM
Eur J Cancer Clin Oncol; 1985 Oct; 21(10):1253-60. PubMed ID: 4076289
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of l-OHP in mice.
Mathé G; Kidani Y; Noji M; Maral R; Bourut C; Chenu E
Cancer Lett; 1985 Jun; 27(2):135-43. PubMed ID: 4039973
[TBL] [Abstract][Full Text] [Related]
14. Antitumor effects of three platinum complexes, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)-platinum (II) monohydrate (DWA2114R), cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) (CBDCA) and cis-diamminedichloroplatinum(II) (CDDP), in mice.
Endo K; Akamatsu K; Matsumoto T; Morikawa K; Koizumi M; Mitsui H; Koizumi K
Anticancer Res; 1992; 12(1):49-58. PubMed ID: 1567181
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo antineoplastic activity of a new platinum antineoplastic agent, (R)-(-)-1,1-cyclobutanedicarboxylate (2-aminomethylpyrrolidine)-platinum (II) (DWA2114R) on freshly separated human tumor cells and human tumor xenografts transplanted in nude mice--a comparison with cis-diammine-dichloroplatinum (CDDP).
Nio Y; Imai S; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Tobe T
Anticancer Res; 1991; 11(2):761-7. PubMed ID: 2064331
[TBL] [Abstract][Full Text] [Related]
16. Oxaliplatin in ovarian cancer.
Sessa C; ten Bokkel Huinink WW; du Bois A
Ann Oncol; 1999; 10 Suppl 1():55-7. PubMed ID: 10219454
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of a new platinum complex, 2-aminomethyl-pyrrolidine (1, 1-cyclobutanedicarboxylato) platinum (II).
Endoh K; Akamatsu K; Matsumoto T; Morikawa K; Honda M; Mitsui H; Koizumi M; Koizumi K; Matsuno T
Anticancer Res; 1989; 9(4):987-91. PubMed ID: 2817826
[TBL] [Abstract][Full Text] [Related]
18. Radiosensitization by oxaliplatin in a mouse adenocarcinoma: influence of treatment schedule.
Cividalli A; Ceciarelli F; Livdi E; Altavista P; Cruciani G; Marchetti P; Danesi DT
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):1092-8. PubMed ID: 11958906
[TBL] [Abstract][Full Text] [Related]
19. In vivo model development of cisplatin-resistant and -sensitive A2780 human ovarian carcinomas.
Rose WC; Basler GA
In Vivo; 1990; 4(6):391-6. PubMed ID: 2103379
[TBL] [Abstract][Full Text] [Related]
20. Organo-platinum complexes as antitumor agents (review).
Hill JM; Speer RJ
Anticancer Res; 1982; 2(3):173-86. PubMed ID: 6751211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]